Skip to main content
Orum Therapeutics, Inc. logo

Orum Therapeutics, Inc. — Investor Relations & Filings

Ticker · 475830 ISIN · KR7475830006 KO Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-08-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 475830

About Orum Therapeutics, Inc.

https://www.orumrx.com/

Orum Therapeutics is a clinical-stage biotechnology company that develops targeted protein degradation (TPD) therapeutics. The company's proprietary TPD²® platform creates a novel class of antibody-drug conjugates (ADCs), referred to as degrader-antibody conjugates (DACs). This technology combines the cell-targeting precision of antibodies with the catalytic action of protein degraders. The approach is designed to selectively deliver payloads to diseased cells to eliminate intracellular proteins that are difficult to target with conventional drugs. Orum's primary focus is on developing treatments for cancer, aiming to improve efficacy and safety over existing therapies.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (due to market transactions), and the purpose of holding (influence on management) by the major shareholder and related parties. This corresponds to the 'Major Shareholding Notification' category.
2025-08-29 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for Orum Therapeutics, covering the period from January 1, 2025, to June 30, 2025. It contains detailed company information, business descriptions, pipeline status, and financial data, which is characteristic of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership, including the reporting of special relationships, changes in share counts, and reasons for the report (such as market trades and changes in issued shares). This falls under the category of Major Shareholding Notification.
2025-08-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a mandatory regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (influencing management) for a major shareholder (Lee Sung-joo) and their special related parties in Orum Therapeutics. This type of filing is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-08 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on August 1, 2025. It details the resolutions passed, including the appointment of directors, capital reserve reduction, stock option grants, and amendments to the articles of incorporation. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-08-01 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to directors and employees, including specific grant dates, exercise prices, and valuation methodologies. In the context of Korean corporate filings (DART system), this is a standard regulatory disclosure regarding capital structure changes and incentive plans, which falls under the 'Regulatory Filings' category as it is a specific statutory disclosure requirement.
2025-08-01 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.